1. Evaluation of QT Liability for PF‐05251749 in the Presence of Potential Circadian Rhythm Modification. (25th December 2019) Authors: Huh, Yeamin; Chen, Danny; Riley, Steve; Chang, Cheng; Nicholas, Timothy Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 9:Number 1(2020) Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Population pharmacokinetic modelling and simulation of tafamidis in healthy subjects and patients with transthyretin amyloidosis. Issue 9 (1st March 2021) Authors: Huh, Yeamin; Riley, Steve; Harnisch, Lutz; Nicholas, Timothy Journal: British journal of clinical pharmacology Issue: Volume 87:Issue 9(2021) Page Start: 3574 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Response Letter to the Editor: "Assumption Checking Before Application of the Prespecified QT Linear Mixed Effect Model is Essential". (8th June 2020) Authors: Huh, Yeamin; Riley, Steve; Nicholas, Timothy Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 9:Number 7(2020) Page Start: 372 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗